Supporter News

Webinar: Unravelling ASH’s key topics: Patient and HCP perspectives

23rd January 2025 Source: https://acuteleuk.org (visit site)
This webinar presented highlights from ASH congress that took place in December 2024. Presentation: Unravelling ASH’s key topics: Patient and HCP perspectives Recording: Additional information: Unanswered Qs_Webinar- Unravelling ASH’s key topics- Patient and HCP perspectives January 22, 2025 We thank both speakers Dr Charles Craddock and Charles McGrath for their time and their commitment to…

Webinar: Unravelling ASH’s key topics: Patient and HCP perspectives

23rd January 2025 Source: https://acuteleuk.org (visit site)
This webinar presented highlights from ASH congress that took place in December 2024. Presentation: Unravelling ASH’s key topics: Patient and HCP perspectives Recording: Additional information: Unanswered Qs_Webinar- Unravelling ASH’s key topics- Patient and HCP perspectives January 22, 2025 We thank both speakers Dr Charles Craddock and Charles McGrath for their time and their commitment to…

Highlights from ASH – Infographic gallery

16th January 2025 Source: https://acuteleuk.org (visit site)
Download your copy and discover the core insights from ASH Congress, condensed into a dynamic infographic. Acute lymphoblastic leukemia (ALL) Chemotherapy-free treatment for older adults with ALL Chemotherapy-free treatment for older adults with ALL Impact of immunotherapy in Philadelphia negative ALL Impact of immunotherapy in Philadelphia negative ALL Obe-cel CAR T-cell therapy in B-cell ALL Obe-cel CAR…

Additional insights from the 2023 Global Leukemia Experience Survey: CLL specific findings, unmet needs and recommendations for action – Now published on the CLLAN Website!

We are pleased to share additional insights from the “2023 Global Leukemia Experience Survey: CLL specific findings, unmet needs and recommendations for action“. The Chronic Lymphocytic Leukaemia Advocates Network (CLLAN) conducted an analysis of the 2023 Global Leukemia Experience Survey data to examine diagnostic pathways, immunity status, and treatment decision experiences of people with CLL.…

Highlights from ASH 2024 – Updates in AML

18th December 2024 Source: https://acuteleuk.org (visit site)
UPDATES IN AML The following summaries highlight key findings from research posters presented at the 66th ASH Annual Meeting, showcasing new developments in oral maintenance therapies for acute myeloid leukemia (AML). In AML, relapses are common after remission. These treatments aim to help patients stay in remission longer while offering convenient, at-home options. Oral Combination…

Highlights from ASH 2024 – Updates in ALL

18th December 2024 Source: https://acuteleuk.org (visit site)
Updates in ALL These research updates were presented at the 66th American Society of Hematology (ASH) Congress. The focus was on new treatments and approaches for acute lymphoblastic leukemia (ALL). ALL can sometimes return after treatment (relapse) or the leukemia can fail to respond to initial treatments (refractory disease), making it harder to achieve long-term…

In Conversation with… The Steering Committee Members of the MPN Advocates Network

The MPN Advocates Network (MPN AN) is delighted to share a special vlogcast featuring its Steering Committee members. Hosted by Nona from MPN Voice, this engaging conversation sheds light on the people behind the network, their roles, and their vision for the future of MPN advocacy. We are incredibly grateful to Nona and MPN Voice…

ASH 2024

9th December 2024 Source: https://acuteleuk.org (visit site)
From 06th to 10th December 2024, Jan, Charles, Catherine and Cheryl attended the 66th ASH Annual Meeting and Exposition in San Diego (USA). ASH‘s annual meeting typically attracts over 30,000 participants, including clinicians, researchers, and healthcare professionals focused on hematology across the world, including a rather homeopathic but energetic number of patient advocates.  Before leaving,…